SuppreMol to present SM101 clinical data
The ongoing phase Ib/IIa trial has assessed efficacy, safety and duration of response to SM101 in 36 ITP patients. The company will report the data under the title
The ongoing phase Ib/IIa trial has assessed efficacy, safety and duration of response to SM101 in 36 ITP patients. The company will report the data under the title
Hosted by PerkinElmer, RGH Summit shares research and promotes collaboration among researchers and practitioners as they deploy disruptive technologies and approaches to support research to prevent, detect, and
In addition, the company will use the fund to complete pre-clinical development of oral plasma DME drug and prepare for Phase I clinical development. Plasma kallikrein, which has
ISIS-TTR Rx is an antisense drug being developed by GSK to treat TTR amyloidosis, a genetic disease characterized by progressive dysfunction of peripheral nerves and/or heart tissue. The
Loblaw’s stores across Canada include Atlantic Superstore, Reasl Canadian Superstore, Zehrs, Fortinos, Your Independent Grocer, No Frills, and many others. Honibe honey lozenges are intended for the temporary
Total revenues for third quarter of 2012 were $85.23m compared to $83.77m for the third quarter of 2011. The company reported a net income of $162.26m, or $1.08
Probiotics are living microorganisms commonly present in yogurt or dietary supplements, which are expected to have beneficial effects. According to study lead author and McGill University Faculty of
The oral CDK inhibitor, CYC065, is a second generation aminopurine which targets similar CDK/cyclin complexes including CDK2, CDK5 and CDK9 to those targeted by seliciclib, a first generation
As per the sales and marketing deal, Seyer Pharmatec will start promoting the product in January 2013. Medicure president and COO Dawson Reimer said Seyer Pharmatec has a
As part of the genome interpretation, Cypher Genomics researchers will incorporate the knowledgebase in Genome Trax to assist in interpretation of next generation sequencing variants to give genomic